Beta adrenoceptor blockade and responses of serum lipids to a meal and to exercise.
- 16 June 1984
- Vol. 288 (6433) , 1788-1790
- https://doi.org/10.1136/bmj.288.6433.1788
Abstract
During a randomised placebo controlled trial of the effects of nadolol in hypertensive patients serum lipid profiles were obtained while the patients were fasting and during and after a meal and an exercise test. Treatment with nadolol was associated with a significant reduction in high density lipoprotein cholesterol at all time points. Serum triglyceride concentrations during treatment with nadolol were higher in the fasting state, though not significantly so, increased further postprandially, and were significantly higher during and after exercise. The changes in high density lipoprotein cholesterol and triglyceride concentrations during beta adrenoceptor blockade may be secondary to a reduction in lipoprotein lipase activity.This publication has 33 references indexed in Scilit:
- Terbutaline Raises High-Density-Lipoprotein-Cholesterol LevelsNew England Journal of Medicine, 1981
- Effect of long-term treatment with beta-blocking drugs on plasma lipids and lipoproteins.BMJ, 1981
- Effect of slow oxprenolol and a combination of slow oxprenolol and cyclopenthiazide on plasma lipoproteinsAtherosclerosis, 1981
- Lipoprotein-lipase action determining plasma high density lipoprotein cholesterol level in adult normolipaemicsAtherosclerosis, 1980
- EFFECT OF PROPRANOLOL AND PRAZOSIN ON BLOOD LIPIDSThe Lancet, 1980
- Metabolic consequences of atenolol and propranolol in treatment of essential hypertension.BMJ, 1979
- Fluorometric Determination of Nadolol in Human Serum and UrineJournal of Pharmaceutical Sciences, 1977
- Comparative effects of acebutolol and practolol on the lipolytic response to isoprenaline.British Journal of Clinical Pharmacology, 1976
- Metabolic Effects of β-Adrenoreceptor BlockersDrugs, 1976
- Propranolol and hypertriglyceridemiaAtherosclerosis, 1973